Are you Dr. Jackson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 45 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
80 Doctors Dr Ste 1
Hendersonville, NC 28792Phone+1 828-654-0073Fax+1 828-681-5036- Is this information wrong?
Summary
- Dr. Don Jackson Jr., MD is an oncologist in Hendersonville, North Carolina. He is currently licensed to practice medicine in North Carolina. He is affiliated with AdventHealth Hendersonville, Mission Hospital, and Charles George Veterans Affairs Medical Center.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1977 - 1978
Wake Forest University Baptist Medical CenterFellowship, Hematology and Medical Oncology, 1975 - 1977- Wake Forest University School of MedicineResidency, Internal Medicine, 1973 - 1975
Carilion Clinic-Virginia Tech Carilion School of MedicineInternship, Transitional Year, 1972 - 1973
University of Virginia School of MedicineClass of 1972
Certifications & Licensure
NC State Medical License 1978 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- HER2 FISH ratio cut-points and pathologic complete response (pCR), residual tumor (RT), HER2 status, and survival prediction in HER2-positive breast cancer (BC).Mehta RS, Jackson D, Schubbert T, Hsiang D> ;J. Clin. Oncol.. 2009-05-20
- DOSE‐RELATED PHARMACOLOGIC EFFECTS OF HIGH DOSE ARA‐C AND ITS USE IN COMBINATION WITH ASPARAGINASE FOR THE TREATMENT OF PATIENTS WITH ACUTE NON‐LYHPHOCYTIC LEUKEMIA*Robert L. Capizzi, Bayard L. Powell, M. Robert Cooper, James P. Rathmell, J. Courtland White, Hyman B. Muss, Frederick Richards, Don V. Jackson, John J. Stuart, Dougla...> ;Scandinavian Journal of Haematology. Supplementum. 2009 Apr 24
- A novel low molecular weight inhibitor of focal adhesion kinase and insulin-like growth factor-1 receptor, TAE226, inhibits glioma growth.Rich JN, Shi Q, Hjelmeland AB, Keir ST, Wickman S, Wu G, Jackson D, Ohmori O, Bigner DD, Friedman HS> ;J. Clin. Oncol.. 2006-06-20
- Join now to see all
Press Mentions
Helping Drug Users Survive, Not Abstain: ‘Harm Reduction’ Gains Federal SupportJune 27th, 2021
Professional Memberships
- Member
Hospital Affiliations
- Mission Hospital McDowellMarion, North Carolina
Mission HospitalAsheville, North Carolina
Charles George Veterans Affairs Medical CenterAsheville, North Carolina
AdventHealth HendersonvilleHendersonville, North Carolina
